Ottawa clinical research a world class endeavour May 2, 2012Dr. Barry Dworkin Madely Health Headlines Commentary for May 2, 2012 [display_podcast] Related posts: HIV treatment with modified T cells successful in small study Unpublished pharma data states it has Hep C treatment cure rate of 99 percent Attacking B-cell lymphoma without chemotherapy using gold nanoparticle Bee venom/nanoparticle combo selectively kills HIV Clinical research